AGX818

SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen

suitable for ELISA, suitable for immunodiffusion

• Synonym(s): 2019-nCoV, COVID-19
• UNSPSC Code: 51201600
• NACRES: NA.26

Properties

• recombinant: expressed in HEK 293 cells
• Quality Level: 100
• form: liquid
• mol wt: ≤76 kDa
• storage condition: avoid repeated freeze/thaw cycles
• technique(s): ELISA: suitable; immunodiffusion: suitable; lateral flow assay: suitable
• shipped in: dry ice

Description

General description

COVID-19 Spike Protein S1 (aa 1-681) Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX818 is tested for use in ELISA, Lateral Flow Assay as Positive Control.

Target description

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 spike antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

Physical form

Purified in 10mM Phosphate Buffered Saline with 0.09% sodium azide, pH 7.0.

Reconstitution

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Storage and Stability

Stable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Safety Information

• Storage Class Code: 12 - Non Combustible Liquids
• WGK: WGK 2
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable